Evidence map›Paper›PMID 37631933›Full record

ReviewVaccines2023

Attitudes towards COVID Vaccine and Vaccine Hesitancy in Dermatology: A Narrative Review.

Woo Chiao Tay, Anthony Bewley, Julia-Tatjana Maul, Hazel H Oon

Abstract readReview
In one paragraph

Review in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Vaccination in dermatology 2025: Update considering current recommendations of the German Standing Committee on Vaccination.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Woo Chiao TayNational Skin Centre, 1 Mandalay Road, Singapore 308205, Singapore.ORCID 0000-0003-3477-8892
Anthony BewleyDepartment of Dermatology, Barts Health NHS Trust, London E11 1NR, UK.
Julia-Tatjana MaulDepartment of Dermatology and Venereology, University Hospital of Zurich, 8091 Zurich, Switzerland.ORCID 0000-0002-9914-1545
Hazel H OonNational Skin Centre, Skin Research Institute of Singapore, 1 Mandalay Road, Singapore 308205, Singapore.ORCID 0000-0001-7607-3124

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccine hesitancy has been a contentious issue even before the pandemic. The COVID-19 crisis has further amplified vaccine hesitancy, with worries about adverse effects, cultural and religious beliefs, and misinformation on social media. In dermatology, patients with pre-existing skin conditions may have specific concerns about the impact of the vaccine on their skin health. Factors such as cutaneous reactions, potential flares of underlying conditions, and fears of psoriasis worsening post-vaccination contribute to vaccine hesitancy. Healthcare professionals, including dermatologists, play a crucial role in addressing vaccine hesitancy by providing accurate information, addressing concerns, and understanding the psychological impact on patients. The concept of vaccine fatigue is also explored, noting the challenges in sustaining vaccine acceptance over time, especially with regards to booster vaccinations. Overcoming vaccine hesitancy requires trust-building, effective communication strategies, and collaboration between healthcare workers and non-healthcare individuals to combat misinformation. By recognizing and addressing psychological factors, dermatologists can increase vaccine acceptance and improve public health efforts.

Indexed as

mental healthpsychodermatologyskin healthsocial isolationvaccine hesitancyvaccines safety

Identifiers

PMID37631933
PMCPMC10459048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.